Literature DB >> 18336295

The Bax Inhibitor-1 (BI-1) family in apoptosis and tumorigenesis.

Kerstin Reimers1, Claudia Y U Choi, Vesna Bucan, Peter M Vogt.   

Abstract

The signaling pathways that determine the fate of a cell regarding death or survival depend on a large number of regulatory proteins. The Bax Inhibitor-1 (BI-1) family is a highly preserved family of small transmembrane proteins located mostly in the endoplasmic reticulum (ER). Although most members of this family are still not characterized an antiapoptotic effect has been described for BI-1, Lifeguard (LFG), and the Golgi anti-apoptotic protein (GAAP). The cytoprotective activity has been associated to the control of ion homeostasis and ER stress but includes other cell death stimuli as well. Recent data describes multiple interactions between the proteins of the BI-1 family and the Bcl-2 family either stimulating the antiapoptotic function of Bcl-2 or inhibiting the proapoptotic effect of Bax. The potent cell death suppression makes this protein family an interesting target for the development of new drugs and gene therapeutic approaches for diseases caused by apoptotic dysregulation, such as cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18336295     DOI: 10.2174/156652408783769562

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  38 in total

1.  Ion and pH Sensitivity of a TMBIM Ca2+ Channel.

Authors:  Gongrui Guo; Min Xu; Yanqi Chang; Tomas Luyten; Bruno Seitaj; Wu Liu; Ping Zhu; Geert Bultynck; Lei Shi; Matthias Quick; Qun Liu
Journal:  Structure       Date:  2019-03-28       Impact factor: 5.006

Review 2.  Autophagy and apoptosis in liver injury.

Authors:  Kewei Wang
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Bax inhibitor-1 is overexpressed in non-small cell lung cancer and promotes its progression and metastasis.

Authors:  Bingjie Lu; Yu Li; Hua Li; Yingmei Zhang; Jin Xu; Lihong Ren; Songbin Fu; Yi Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  Mouse transmembrane BAX inhibitor motif 3 (Tmbim3) encodes a 38 kDa transmembrane protein expressed in the central nervous system.

Authors:  Joseph A Nielsen; Meredith A Chambers; Elena Romm; Laurel Yong-Hwa Lee; Jo Ann Berndt; Lynn D Hudson
Journal:  Mol Cell Biochem       Date:  2011-05-26       Impact factor: 3.396

5.  TMBIM3/GRINA is a novel unfolded protein response (UPR) target gene that controls apoptosis through the modulation of ER calcium homeostasis.

Authors:  D Rojas-Rivera; R Armisén; A Colombo; G Martínez; A L Eguiguren; A Díaz; S Kiviluoto; D Rodríguez; M Patron; R Rizzuto; G Bultynck; M L Concha; J Sierralta; A Stutzin; C Hetz
Journal:  Cell Death Differ       Date:  2012-01-13       Impact factor: 15.828

6.  Prdm16 is a physiologic regulator of hematopoietic stem cells.

Authors:  Francesca Aguilo; Serine Avagyan; Amy Labar; Ana Sevilla; Dung-Fang Lee; Parameet Kumar; Ihor R Lemischka; Betty Y Zhou; Hans-Willem Snoeck
Journal:  Blood       Date:  2011-02-22       Impact factor: 22.113

Review 7.  BAX inhibitor-1: between stress and survival.

Authors:  Cynthia Lebeaupin; Marina Blanc; Déborah Vallée; Harald Keller; Béatrice Bailly-Maitre
Journal:  FEBS J       Date:  2020-01-08       Impact factor: 5.542

8.  BAX inhibitor-1 regulates autophagy by controlling the IRE1α branch of the unfolded protein response.

Authors:  Karen Castillo; Diego Rojas-Rivera; Fernanda Lisbona; Benjamín Caballero; Melissa Nassif; Felipe A Court; Sebastian Schuck; Consuelo Ibar; Peter Walter; Jimena Sierralta; Alvaro Glavic; Claudio Hetz
Journal:  EMBO J       Date:  2011-09-16       Impact factor: 11.598

9.  Proteome alterations in primary human alveolar macrophages in response to influenza A virus infection.

Authors:  Lin Liu; Jianhong Zhou; Yimeng Wang; Robert J Mason; Cornelius Joel Funk; Yuchun Du
Journal:  J Proteome Res       Date:  2012-07-05       Impact factor: 4.466

Review 10.  Cell death and survival through the endoplasmic reticulum-mitochondrial axis.

Authors:  R Bravo-Sagua; A E Rodriguez; J Kuzmicic; T Gutierrez; C Lopez-Crisosto; C Quiroga; J Díaz-Elizondo; M Chiong; T G Gillette; B A Rothermel; S Lavandero
Journal:  Curr Mol Med       Date:  2013-02       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.